-
AbMeta Therapeutics, launched by biologist and Provost Denis Wirtz, bioengineer Jamie Spangler, and clinician Elizabeth Jaffee, will combine years of pioneering research to target metastasis Read More
-
A team from the Institute for NanoBioTechnology has streamlined the creation of new viral vectors for delivering gene therapy to patients Read More
-
Johns Hopkins researchers identify a key protein in the regulation of cancer metastasis Read More
-
-
-
INBT’s co-founders Peter Searson and Denis Wirtz had a vision. Searson, the Joseph R. and Lynne C. Reynolds Professor of Engineering and a professor of materials science and engineering, and… Read More
